Women across the country are opting to use power morcellator devices for their hysterectomy or other similar procedures, even though the FDA and medical professionals grow increasingly worried over its safety concerns.

When used in gynecological procedures, these devices have been allegedly inducing morcellator cancer in a number of female patients.

Power morcellator devices became popular almost as soon as they were available, due to their minimally invasive procedure process on delicate surgeries like hysterectomies.

Not only were these surgical tools advertised to be more accurate, but they also promised quicker recovery time than the traditional procedure.

However these devices have been allegedly causing patients with previously undiagnosed uterine cancer to suddenly have a latent stage prognosis upon discovery.

Power morcellator devices consist of two tiny rotating blades designed to cut up uterine fibroids and other tissue. Once the fibroids are sliced into tiny pieces they are then vacuumed out through a tube, which is inserted from a small incision in the abdomen. However, small undetected cancerous pieces can be spread.

So even though this provides surgeons and patients a convenient method for delicate procedures, experts are now questioning if it is worth the risk.

Overview of Power Morcellator Cancer

In April 2014, the FDA issued a safety alert that discouraged surgeons from using power morcellator devices for laparoscopic procedures.

The agency explained that these devices posed a significant risk of morcellator cancer, a term often used to describe uterine cancer that was allowed to significantly develop after the power morcellator surgery.

In addition, these devices significantly decrease the chances of long term survival after diagnosis of morcellator cancer.

As mentioned before, power morcellator devices consist of tiny rotating blades meant to cut up fibroids for removal, but this mechanism consequently spreads fibroid tissue to other places in abdominal cavity.

In doing this, undiagnosed cancer cells can be released into the body and then allowed to spread at a much faster rate than the cells would normally be able to.

At this time, there is no diagnostic method available to determine if a woman has uterine cancer before undergoing power morcellator surgery. The FDA currently estimates that there are approximately one in 350 women with undiagnosed uterine cancer, which is significant for a surgical tool used in numerous procedures per year.

A number of hospitals have stopped providing power morcellator surgery as an option for patients, while many of the power morcellator manufacturers have recalled their devices.

It has been reported that the risk of morcellator cancer is significantly decreased when a surgical bag is used to catch the tissue debris released during surgery.

However many surgeons have stopped using the device regardless, especially when the morcellator cancer risk is often at a latent stage soon after the surgery.

A number of women have filed legal action against power morcellator manufacturers for failing to warn them against the risk of morcellator cancer.

Potential claimants should contact a specialized lawyer, to determine if they are eligible for a power morcellator lawsuit.